Founders Financial Securities LLC Dexcom Inc Transaction History

Founders Financial Securities LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 17, 2023	BUY	$86.06 - $137.93 $21,170 - $33,930	246 Added 7.6%	3,483 $324,000
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $29,579 - $34,447	263 Added 8.84%	3,237 $415,000
Q1 2023 May 04, 2023	BUY	$104.0 - $122.92 $13,832 - $16,348	133 Added 4.68%	2,974 $345,000
Q4 2022 Feb 08, 2023	SELL	$84.98 - $122.67 $254 - $368	-3 Reduced 0.11%	2,841 $321,000
Q3 2022 Oct 27, 2022	SELL	$76.35 - $94.18 $5,955 - $7,346	-78 Reduced 2.67%	2,844 $229,000
Q2 2022 Jul 27, 2022	BUY	$67.99 - $132.89 $156,444 - $305,779	2,301 Added 370.53%	2,922 $218,000
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $12,042 - $16,665	128 Added 25.96%	621 $318,000
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $2,337 - $2,930	18 Added 3.79%	493 $265,000
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $50,687 - $68,010	475 New	475 $260,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Founders Financial Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Founders Financial Securities LLC with notifications on news.